These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2188785

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The interaction of parathyroid hormone and aluminum in renal osteodystrophy.
    Slatopolsky E.
    Kidney Int; 1987 Mar; 31(3):842-54. PubMed ID: 3573543
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fluoride and dialysis osteodystrophy: results of a double-blind study.
    Oreopoulos DG, Taves DR, Rabinovich S, Meema HE, Murray T, Fenton SS, deVeber GA.
    Trans Am Soc Artif Intern Organs; 1974 Mar; 20A():203-8. PubMed ID: 4615422
    [No Abstract] [Full Text] [Related]

  • 11. [Prevention and treatment of renal osteodystrophy: present and future].
    Fernández E, Craver L.
    Nefrologia; 2006 Mar; 26 Suppl 3():19-27. PubMed ID: 17469423
    [No Abstract] [Full Text] [Related]

  • 12. [Diet in the prevention of uremic osteodystrophy].
    Maschio G, D'Angelo A, Bonucci E, Tessitore N, Lo Schiavo C, Lupo A, Valvo E, Chiaramonte S, Previato G, Fabris A, Saporiti E, Fiaschi E.
    G Clin Med; 1980 May; 61(5):358-64. PubMed ID: 7450355
    [No Abstract] [Full Text] [Related]

  • 13. [Correlations between osteodensitometry and parameters of uremic osteodystrophy].
    Sforzini S, Viganò MR, Beretta P, Rosa M, d'Amico P, Lomuscio G, Paesani R.
    Minerva Med; 1985 Mar 10; 76(9-10):445-8. PubMed ID: 3982703
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vitamin D therapy in uremic osteodystrophy: theoretical and practical considerations.
    Popovtzer MM.
    Int J Artif Organs; 1980 Jan 10; 3(1):1-4. PubMed ID: 7353907
    [No Abstract] [Full Text] [Related]

  • 16. Pathogenesis of uremic osteodystrophy.
    Agus ZS, Goldberg M.
    Radiol Clin North Am; 1972 Dec 10; 10(3):545-56. PubMed ID: 4566892
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Noninvasive diagnosis of uremic osteodystrophy: uses and limitations.
    Heaf JG, Joffe P, Pødenphant J, Andersen JR.
    Am J Nephrol; 1987 Dec 10; 7(3):203-11. PubMed ID: 3631150
    [Abstract] [Full Text] [Related]

  • 19. Aluminium-induced bone disease in uremic rats: effect of deferoxamine.
    Jablonski G, Klem KH, Danielsen CC, Mosekilde L, Gordeladze JO.
    Biosci Rep; 1996 Feb 10; 16(1):49-63. PubMed ID: 8861540
    [Abstract] [Full Text] [Related]

  • 20. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Johnson JR, George CR, Collett P, Kalowski S.
    Q J Med; 1985 May 10; 55(217):127-44. PubMed ID: 4001311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.